Based on the expression profiles and outcome data in the GEPIA database, we found that ACADSB and MYCN are the favorable prognostic marker of ccRCC, while CDCA3, CHAC1, and TFAP2A are the unfavorable prognostic marker of ccRCC (Figure S2). This evidence concerns the gene ACADSB and nonpapillary renal cell carcinoma.